ASSEMBLY, No. 4732

STATE OF NEW JERSEY

219th LEGISLATURE

 

INTRODUCED SEPTEMBER 24, 2020

 


 

Sponsored by:

Assemblyman  BRIAN BERGEN

District 25 (Morris and Somerset)

 

 

 

 

SYNOPSIS

     Requires tobacco product retailers to carry and offer for sale certain tobacco use cessation products.

 

CURRENT VERSION OF TEXT

     As introduced.

  


An Act concerning tobacco product retailers and supplementing Title 2A of the New Jersey Statutes.

 

     Be It Enacted by the Senate and General Assembly of the State of New Jersey:

 

     1.    a.  Any entity that sells, offers for sale, or distributes for commercial purpose any tobacco product shall maintain a stock of, and offer for retail sale, at least one type of nicotine replacement therapy drug, device, or combination product that has been approved by the federal Food and Drug Administration for cessation of tobacco use pursuant to the “Federal Food, Drug, and Cosmetic Act,” 21 U.S.C. ss.301 et seq.

     b.    As used in this section, “tobacco product” means any product containing, made of, or derived from tobacco or nicotine that is intended for human consumption or is likely to be consumed, whether inhaled, absorbed, or ingested by other means, including, but not limited to, a cigarette, cigar, pipe tobacco, chewing tobacco, snuff, or snus; any vapor product; and any component, part, or accessory of a product containing, made of, or derived from tobacco or nicotine or a vapor product, regardless of whether the component, part, or accessory contains tobacco or nicotine.  “Tobacco product” includes, but is not limited to, filters, rolling papers, blunt or hemp wraps, hookahs, and pipes. 

 

     2.    This act shall take effect 60 days after the date of enactment.

 

 

STATEMENT

 

     This bill requires any entity that sells, offers for sale, or distributes for commercial purpose any tobacco product to maintain a stock of, and offer for retail sale, at least one type of nicotine replacement therapy drug, device, or combination product that has been approved by the federal Food and Drug Administration for cessation of tobacco use.

     As used in the bill, “tobacco product” means any product containing, made of, or derived from tobacco or nicotine that is intended for human consumption or is likely to be consumed, whether inhaled, absorbed, or ingested by other means.  The term includes component parts, accessories, and other related items.